Showing results (111-120 of 126) with videos related to

Sort By:
Pageof 13
Anticancer Research|June 4, 2020
Diagnostic Reliability, Accuracy and Safety of Ultrasound-guided Biopsy and Ascites Puncture in Primarily Inoperable Ovarian TumoursPavel Vlasak, Jiri Bouda, Jan Kostun, et al.
Anticancer Research|March 29, 2022
Oncogenic Fusions in Gliomas: An Institutional ExperienceJiri Polivka, Marian Svajdler, Vladimir Priban, et al.
Anticancer Research|December 1, 2017
Predictive Significance of Thymidylate Synthase Expression in Non-small Cell Lung CancerVlastimil Kulda, Kristyna Hrda, Zbynek Houdek, et al.
Food & Function|October 20, 2020
Chronic n-3 fatty acid intake enhances insulin response to oral glucose and elevates GLP-1 in high-fat diet-fed obese miceJana Pavlisova, Olga Horakova, Veronika Kalendova, et al.
Anticancer Research|April 22, 2011
Evaluation of tumour markers as differential diagnostic tool in patients with suspicion of liver metastases from breast cancerVaclav Liska, Lubos Holubec, Vladislav Treska, et al.
Anticancer Research|April 30, 2016
Change in Serum Lactate Dehydrogenase Is Associated with Outcome of Patients with Advanced-stage NSCLC Treated with ErlotinibOndrej Fiala, Milos Pesek, Jindrich Finek, et al.
Anticancer Research|December 27, 2011
Growth factors and breast tumors, comparison of selected growth factors with traditional tumor markersRadek Kucera, Monika Cerna, Andrea Narsanska, et al.
Anticancer Research|September 3, 2021
BAI1 as a Prognostic Marker of Clear Cell Renal Cell Carcinoma (ccRCC)Martin Pesta, Ivan Travnicek, Vlastimil Kulda, et al.
Anticancer Research|October 25, 2017
Serum Concentration of Erlotinib and its Correlation with Outcome and Toxicity in Patients with Advanced-stage NSCLCOndrej Fiala, Petr Hosek, Milos Pesek, et al.
Anticancer Research|November 24, 2011
Prognostic significance of TIMP-1 in non-small cell lung cancerMartin Pesta, Vlastimil Kulda, Radek Kucera, et al.
Pageof 13